The head-to-head fight for PCSK9 reimbursement ended in a tie. At Express Scripts ($ESRX), both Sanofi ($SNY) and Regeneron's ($REGN) Praluent and Amgen's ($AMGN) Repatha scored a spot on the preferred formulary, which gives both products a chance to snare the pharmacy benefits manager's patients. Discounts on both meds, together with strict limits on patient eligibility, mean Express Scripts can cover Praluent and Repatha without breaking the bank, the PBM said Tuesday. More from FiercePharma